Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Fluoroquinolones and acute kidney injury

By News team

Oral fluoroquinolones are associated with a small, but significant, increased risk of acute kidney injury, US researchers report (Canadian Medical Association Journal, online 3 June 2013).

A case-control study involving men aged 40 to 85 years found current quinolone use to be associated with a two-fold increased risk of acute kidney injury requiring hospital admission. The absolute increase was 6.5 events per 10,000 person years. There was a 4.5-fold increase in risk of acute kidney injury with combined use of quinolone and renin angiotensin system blockers, and the researchers caution against concomitant use.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2013.11122080

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.